ExoTIC Microfluidic Chip for High-Yield Exosome Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating exosomes from clinical samples are expensive, time-consuming, and result in low yields and poor purity, hindering their application in cancer diagnosis and drug delivery.

Innovation Solution

The ExoTIC device, a cost-effective, single-step, size-based filtration system that efficiently isolates exosomes from various biofluids, allowing for high-yield and high-purity exosome preparations, facilitating their use in biomarker identification and disease monitoring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional exosome purification methods (ultracentrifugation, multi-step filtration, antibody conjugated magnetic beads, or polyethylene glycol based precipitation) are used, then exosome isolation can be achieved, but the process becomes expensive, time-consuming, requires large sample volumes, frequent manual handling, and results in poor yields and unpredictable purity

Engineering Contradiction:
Improveexosome isolation efficiencyVSAvoidpurification time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The flow chamber is divided into multiple regions with membranes of different pore sizes arranged in series. Exosomes are sequentially separated by size as the sample flows through each membrane region, enabling fractionation without complex manual handling steps.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The device integrates multiple filtration functions into a single chip structure. A single device can process different sample types (plasma, serum, urine, cell culture media) and perform size-based separation, concentration, and purification simultaneously, eliminating the need for multiple separate purification steps.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If conventional exosome purification methods are used, then exosome isolation can be achieved, but the process requires large sample volumes and frequent manual handling

Engineering Contradiction:
Improveexosome isolation efficiencyVSAvoidmanual handling requirement
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The device enables self-contained exosome purification where the integrated microfluidic chip performs all separation, filtration, and concentration steps automatically as sample flows through the system. The structure itself provides the separation mechanism without requiring external manual intervention for each purification step.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Multiple purification operations (filtration, centrifugation-like separation, concentration) are merged into a single integrated chip device. The combination of different pore size membranes in series achieves comprehensive purification in one pass, eliminating the need for sequential manual handling of multiple purification steps.

Inventive Principle:
Principle #5Merging (Combining)

3Quantity of substance

If conventional exosome purification methods are used, then exosome isolation can be achieved, but the yield and purity are poor and unpredictable

Engineering Contradiction:
Improveexosome yieldVSAvoidpurity consistency
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

Different regions of the flow chamber are designed with specific pore sizes optimized for capturing exosomes of different dimensions. The gradient of pore sizes from larger to smaller creates zones of selective retention, ensuring that exosomes are captured at optimal locations based on their size characteristics, thereby improving both yield and purity consistency.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The device utilizes membranes with precisely controlled porous structures of different pore sizes. These porous materials provide size-selective filtration where exosomes are retained based on their diameter, enabling consistent separation and purification. The porous structure allows passive capture without requiring complex reagents or multiple handling steps.

Inventive Principle:
Principle #31Porous materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ExoTIC device enables rapid, high-throughput exosome isolation with over 90% recovery, suitable for a wide range of sample volumes, improving the detection of cancer biomarkers and patient outcomes by providing early diagnosis and monitoring capabilities.

Implementation Method 1

a membrane through which the extracellular vesicle-containing sample must flow as the extracellular vesicle-containing sample flows from the inlet to the outlet. Extracellular vesicles are isolated from the extracellular vesicle-containing sample on the membrane with the membrane collecting at least some of the extracellular vesicles on it while permitting a remainder of the extracellular vesicle-containing sample to flow through the membrane

Methodology Applied
Scientific EffectFiltration: Filter (physical)

Data Source

PatentUS11761952B2Exosome-total-isolation-chip (ExoTIC) device for isolation of exosome-based biomarkers
Publication Date: 2023.09.19 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US11761952B2 patent drawing
  • US11761952B2 patent drawing
  • US11761952B2 patent drawing

AI summary

A device (“the ExoTIC device”) for the isolation of extracellular vesicles from an extracellular vesicle-containing sample in which the sample is flowed through a membrane in a flow chamber to capture and purify the extracellular vesicles on the membrane. The extracellular vesicles may be washed and collected and utilized in any one of a number of ways including, but not limited to, identifying biomarkers of a disease, identifying the presence of a biomarker in a patient to determine whether a patient has a disease, and therapeutically treating existing diseases by re-introducing the extracellular vesicles, potentially modified, back into a body.